Beconase Hayfever Relief for Adults Nasal Spray (180 sprays)
- Brand: GlaxoSmithKline
- Product Code: BEC95N
- Availability: In Stock
Our price: £10.49 (inc VAT)
RRP: £10.99 (inc VAT)
As this is a pharmacy medicine, we need to ask you a few confidential questions about your use of the medicine, so that our pharmacist can assess if it is suitable for you.
Rare cases of nasal septal perforation have been reported following the use of intranasal corticosteroids.
As with other nasal sprays, dryness and irritation of the nose and throat, unpleasant taste and smell and epistaxis have been reported rarely.
Rare cases of raised intra-ocular pressure, glaucoma or cataract in association with intranasal formulations of beclomethasone dipropionate have been reported.
Very rare cases of hypersensitivity reactions including rashes, urticaria, pruritus and erythema, and oedema of the eyes, face, lips and throat, anaphylactoid / anaphylactic reactions, dyspnoea and/or bronchospasm have been reported.
50 micrograms beclometasone dipropionate per 100 mg actuation.
Following topical administration, beclometasone 17,21-dipropionate (BDP) produces potent anti-inflammatory and vasoconstrictor effects.
BDP is a pro-drug with weak corticosteroid receptor binding affinity. It is hydrolysed via esterase enzymes to the highly active metabolite beclometasone-17-monopropionate (B-17-MP), which has high topical anti-inflammatory activity.
Beclometasone dipropionate offers a preventative background treatment for hayfever when taken prior to allergen challenge. After which, with regular use, BDP can continue to prevent allergy symptoms from reappearing.
Also contains: Avicel RC 591 (Microcrystalline Cellulose and Carboxymethylcellulose Sodium),Anhydrous Dextrose for parenteral use, Benzalkonium Chloride (added as Benzalkonium Chloride solution), Phenylethyl Alcohol, Polysorbate 80, Purified Water.
Systemic effects of nasal corticosteroids may occur, particularly at high doses when used for prolonged periods.
Treatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used then additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.
Medical advice should be sought before using Beconase Hayfever Relief for Adults by patients using other forms of corticosteroid treatments such as asthma medications, tablets, injections, similar nasal sprays, eye or nose drops, creams, ointments.
This product should not be used continuously for longer than 1 month without medical advice.
Infections of the nasal passages and paranasal sinuses should be appropriately treated but do not constitute a specific contra-indication to treatment with Beconase Hayfever Relief for Adults.
Although Beconase Hayfever Relief for Adults will control seasonal allergic rhinitis in most cases, an abnormally heavy challenge of summer allergens may, in certain instances, necessitate appropriate additional therapy particularly to control eye symptoms.
Medical advice should be sought before using Beconase Hayfever Relief for Adults in the case of recent injury or surgery to the nose, or problems with ulceration in the nose.
The use of beclometasone dipropionate should be avoided during pregnancy unless thought essential by the doctor.
Beconase Hayfever Relief for Adults should not be used during lactation without consulting a doctor.
After first opening the shelf life is 3 months.
Beconase Hayfever Relief for Adults should not be stored above 30Â°C. Keep container in the outer carton. Do not refrigerate.
Adults aged 18 and over: The recommended dosage is two sprays into each nostril morning and evening (400 micrograms/day). Once control has been established, it may be possible to maintain control with fewer sprays. A dosage regimen of one spray into each nostril morning and evening has been shown to be efficacious in some patients. However, should the symptoms recur, patients should revert to the recommended dosage of two sprays into each nostril morning and evening. The minimum dose should be used at which effective control of symptoms is maintained. Total daily administration should not exceed eight sprays (400 micrograms).
Beconase Hayfever Relief for Adults quickly starts to reduce inflammation and swelling in the nose. For full therapeutic benefit Beconase Hayfever Relief for Adults should be used regularly.
If symptoms have not improved after 7 days treatment, medical advice must be sought.
Beconase Hayfever Relief for Adults is not for use by children or adolescents under 18 years of age.